Almorexant

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAlmorexant
Drug Alias NameAlmorexantum阿莫伦特阿莫雷生奥莫雷生ACT-078573 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonistsOrexin receptor type 2 antagonists
TargetsOrexin receptor type 1Orexin receptor type 2
Therapy Area/IndicationsSubstance-Related DisordersSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[22] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMidnight Pharma Llc
Active IndicationsN/A
Inactive IndicationsSubstance-Related DisordersSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG